retatrutide phase 2 results 2024 2025 press release Development History: Discovery to 3 Retatrutide vs Tirzepatide Compared |

A Phase 2 randomised controlled trial published in the New England Journal of Medicine (Jastreboff et al., 2023) reported mean placebo-adjusted weight reductions of up to approximately 24% over 48 weeks in adults with obesity

BPC-157 Peptide may be a suitable treatment for moderate chronic joint pain , tendon injuries, and other ailments, but it is best not to go it alone

doi: 10.2165/00024677-200201030-00005

GLP-1 agonists like Semaglutide produce appetite suppression and slower gastric emptying

Studies show that people who stop GLP-1 medications typically regain at least two-thirds of the weight they lost within one year, and the weight that comes back is mostly fat, not muscle